Hawiger J
Department of Medicine, New England Deaconess Hospital, Boston, Massachusetts 02215.
Ann N Y Acad Sci. 1987;509:131-41. doi: 10.1111/j.1749-6632.1987.tb30990.x.
Adhesive molecules are essential for anchoring platelets to the zone of vascular injury and for linking them together. Among adhesive molecules, von Willebrand factor and fibrinogen bind to platelets "on demand" when their membrane receptors, composed of membrane glycoproteins, are transformed into the binding mode. At least one receptor mechanism for fibrinogen and for vWF is controlled by ADP that is secreted through the known pathways of platelet activation and counterbalanced by cyclic AMP. Structural and functional studies of adhesive macromolecules led to delineation of receptor pathways responsible for the interaction of platelets with the injured vessel wall and with each other. Synthetic peptide analogues of platelet receptor recognition domains evolved from these studies as a new class of inhibitors of platelet aggregation.
黏附分子对于将血小板锚定到血管损伤区域并使它们相互连接至关重要。在黏附分子中,血管性血友病因子和纤维蛋白原在其由膜糖蛋白组成的膜受体转变为结合模式时“按需”与血小板结合。纤维蛋白原和血管性血友病因子的至少一种受体机制受通过血小板激活的已知途径分泌并由环磷酸腺苷平衡的二磷酸腺苷控制。黏附大分子的结构和功能研究导致确定了负责血小板与受损血管壁以及彼此之间相互作用的受体途径。从这些研究中衍生出的血小板受体识别域的合成肽类似物成为一类新型的血小板聚集抑制剂。